On January 24 and 25, 2025, the international symposium of the Collaborative Research Center (SFB) 1066 “Nanomaterials for Tumor Immunotherapy” took place at the Erbacher Hof in Mainz. Researchers from all over the world came together to discuss the latest developments in nanomedical tumor immunotherapy and share groundbreaking findings.
With over 500 publications and groundbreaking therapeutic approaches, the SFB has contributed significantly to the further development of nanomedicine. Funded by the German Research Foundation (DFG), the project will end after twelve years of successful research in mid-2025.
The symposium presented a high-level scientific program with talks by leading international experts. In his opening remarks, Minister Hoch emphasized the importance of interdisciplinary research and the collaboration between science and industry in the field of nanomaterials: “Immunotherapy has become one of the most important cancer treatments, and its further development using nanomaterials offers the opportunity to make this therapy even more effective and precise.”
Poster Prize Winner:
Congratulations to Maximilian Schaaf, who received the Wiley Macromolecular Bioscience Poster Award for his poster on "in vivo targeting of splenic and hepatic cDC1 cells via antibody functionalised liposomes".
Congratulations to Hicham El Mard, who recieved the Wiley Advanced Therapeutics Posterpreis for his poster on "Biodegradable polycarbonate nanocarriers loaded with an interferon-activator for the repolarization of macrophages and myelomonocytic immune cells in an HCC mouse model".
